Non-bacterial thrombotic endocarditis cost-effectiveness of therapy

non-bacterial thrombotic endocarditis
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating non-bacterial thrombotic endocarditis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X-ray
Echocardiography and Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Non-bacterial thrombotic endocarditis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Non-bacterial thrombotic endocarditis cost-effectiveness of therapy
CDC on Non-bacterial thrombotic endocarditis cost-effectiveness of therapy
Non-bacterial thrombotic endocarditis cost-effectiveness of therapy in the news
Blogs on Non-bacterial thrombotic endocarditis cost-effectiveness of therapy
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Non-bacterial thrombotic endocarditis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]